OraSure Technologies Total Current Assets 2010-2024 | OSUR

OraSure Technologies total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
OraSure Technologies Annual Total Current Assets
(Millions of US $)
2023 $386
2022 $325
2021 $299
2020 $289
2019 $225
2018 $219
2017 $222
2016 $156
2015 $137
2014 $131
2013 $120
2012 $120
2011 $53
2010 $97
2009 $105
OraSure Technologies Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $350
2024-06-30 $351
2024-03-31 $349
2023-12-31 $386
2023-09-30 $356
2023-06-30 $342
2023-03-31 $344
2022-12-31 $325
2022-09-30 $280
2022-06-30 $267
2022-03-31 $268
2021-12-31 $299
2021-09-30 $289
2021-06-30 $285
2021-03-31 $292
2020-12-31 $289
2020-09-30 $303
2020-06-30 $318
2020-03-31 $223
2019-12-31 $225
2019-09-30 $223
2019-06-30 $209
2019-03-31 $205
2018-12-31 $219
2018-09-30 $208
2018-06-30 $202
2018-03-31 $197
2017-12-31 $222
2017-09-30 $209
2017-06-30 $206
2017-03-31 $181
2016-12-31 $156
2016-09-30 $151
2016-06-30 $146
2016-03-31 $134
2015-12-31 $137
2015-09-30 $142
2015-06-30 $125
2015-03-31 $123
2014-12-31 $131
2014-09-30 $130
2014-06-30 $116
2014-03-31 $112
2013-12-31 $120
2013-09-30 $111
2013-06-30 $108
2013-03-31 $113
2012-12-31 $120
2012-09-30 $124
2012-06-30 $52
2012-03-31 $50
2011-12-31 $53
2011-09-30 $47
2011-06-30 $97
2011-03-31 $94
2010-12-31 $97
2010-09-30 $97
2010-06-30 $99
2010-03-31 $98
2009-12-31 $105
2009-09-30 $106
2009-06-30 $100
2009-03-31 $101
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.270B $0.405B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.797B 24.85
Boston Scientific (BSX) United States $139.837B 40.20
Stryker (SYK) United States $139.395B 31.41
EssilorLuxottica (ESLOY) France $110.104B 0.00
Medtronic (MDT) Ireland $103.429B 15.36
Lonza Group Ag (LZAGY) Switzerland $43.664B 0.00
Haleon (HLN) United Kingdom $41.193B 26.76
GE HealthCare Technologies (GEHC) United States $38.725B 20.09
ResMed (RMD) United States $34.324B 28.21
Terumo (TRUMY) Japan $28.025B 39.58
Koninklijke Philips (PHG) Netherlands $24.269B 18.58
Zimmer Biomet Holdings (ZBH) United States $20.811B 13.25
Insulet (PODD) United States $19.068B 75.93
Baxter (BAX) United States $15.022B 9.77
Smith & Nephew SNATS (SNN) United Kingdom $10.471B 0.00
Bio-Rad Laboratories (BIO) United States $9.568B 32.52
BellRing Brands (BRBR) United States $9.145B 36.79
Demant (WILYY) Denmark $8.596B 0.00
Lantheus Holdings (LNTH) United States $6.666B 15.49
Haemonetics (HAE) United States $3.851B 18.79
ICU Medical (ICUI) United States $3.779B 35.98
Prestige Consumer Healthcare (PBH) United States $3.656B 18.18
Perrigo (PRGO) Ireland $3.326B 9.79
Envista Holdings (NVST) United States $3.198B 23.82
QuidelOrtho (QDEL) United States $3.077B 19.81
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
Neogen (NEOG) United States $2.678B 30.90
GN Store Nord (GNNDY) Denmark $2.593B 16.63
LeMaitre Vascular (LMAT) United States $2.104B 51.14
Green Thumb Industries (GTBIF) United States $1.564B 27.37
AtriCure (ATRC) United States $1.531B 0.00
AdaptHealth (AHCO) United States $1.364B 9.75
InMode (INMD) Israel $1.335B 8.03
BioLife Solutions (BLFS) United States $1.234B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.225B 0.00
Owens & Minor (OMI) United States $1.071B 8.37
Curaleaf Holdings (CURLF) Canada $0.942B 0.00
Phibro Animal Health (PAHC) United States $0.812B 14.32
CeriBell (CBLL) United States $0.750B 0.00
Evolus (EOLS) United States $0.633B 0.00
Capricor Therapeutics (CAPR) United States $0.600B 0.00
VAREX IMAGING (VREX) United States $0.551B 24.31
Surmodics (SRDX) United States $0.549B 0.00
Omeros (OMER) United States $0.512B 0.00
Cresco Labs (CRLBF) United States $0.459B 0.00
Verano Holdings (VRNOF) United States $0.423B 0.00
ZimVie (ZIMV) United States $0.372B 31.37
Valneva SE (VALN) France $0.369B 0.00
Quanterix (QTRX) United States $0.363B 0.00
Viemed Healthcare (VMD) United States $0.310B 29.44
Biote (BTMD) United States $0.307B 6.73
Cerus (CERS) United States $0.293B 0.00
Sanara MedTech (SMTI) United States $0.282B 0.00
Canopy Growth (CGC) Canada $0.267B 0.00
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.249B 52.20
Aurora Cannabis (ACB) Canada $0.227B 0.00
Sanuwave Health (SNWV) United States $0.224B 3.15
Utah Medical Products (UTMD) United States $0.207B 14.26
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.198B 0.00
Brainsway (BWAY) Israel $0.177B 94.00
TerrAscend (TSNDF) Canada $0.164B 0.00
TriSalus Life Sciences (TLSI) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.137B 17.21
Quipt Home Medical (QIPT) United States $0.129B 0.00
Jin Medical (ZJYL) China $0.126B 0.00
Veru (VERU) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 10.88
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
InterCure (INCR) Israel $0.076B 0.00
INLIF (INLF) $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Exagen (XGN) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.046B 0.00
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.30
SNDL (SNDL) Canada $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00